Trending News
News
News
Agendia Joins the Personalized Medicine Coalition
The company focuses on the development and commercialization of diagnostic tests using tumor gene expression profiling.
News
DxS K-RAS Mutation Detection Kit Used To Assess Tumour Mutation Status Prior to Treatment with Amgen’s Vectibix™
Amgen has selected Kit to analyse patient samples from the pivotal“408” study examining Vectibix versus best supportive care in patients with metastatic colorectal cancer.
News
Molecular Sensing to Commercialize New Biosensor Technology Exclusively Licensed from Vanderbilt University
MSI plans to produce biosensor products for research, diagnostic, biodefense and pharmacogenomic applications.
News
Moffitt Selects Microsoft's Azyxxi to Help Drive Personalized Cancer Treatment
Software to save years in research that aligns patients and treatments.
News
Oxford Genome Sciences Announces New Therapeutic Antibody Deal with Medarex
New agreement to drive the development of OGeS’ own pipeline of antibodies in cancer.
News
FDA Clears Genetic Lab Test for Warfarin Sensitivity
Research has shown that some of the unexpected response to warfarin depends on variants of two genes, CYP2C9 and VKORC1.
News
bioMerieux and Ipsen Sign Theragnostics Agreement to Develop Companion Test for new Breast Cancer Treatment
bioMerieux will develop a companion test for a new breast cancer drug undergoing clinical evaluation by Ipsen.
News
Med BioGene Welcomes Renowned Expert to Lymphoma Collaboration
Med BioGene Inc. has welcomed Sandeep S. Dave, M.D. of Duke University to its lymphoma collaboration.
News
SRI International and Pentax Corporation Develop Biomarkers for Oncology Diagnostics
The ultimate goal of the collaboration is to develop medical diagnostic tools for therapeutic intervention in the treatment of cancer.
News
DxS Signs a License with DiagnoCure for its Scorpions® Technology
DiagnoCure will gain access to Scorpions for the development of their GCC-based molecular test for colorectal cancer.
Advertisement